Estrogen and progesterone modulate [S]GTPγS binding to nociceptin receptors

Neuroendocrinology

Volumn 88, Issue 1, 2008, Pages 35-42

  Quesada, Arnulfo ^a   Micevych, Paul ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

G protein coupled receptor; GTP S; Medial preoptic area; Mediobasal hypothalamus; Opioid receptor 1

Indexed keywords

ESTRADIOL BENZOATE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); NOCICEPTIN RECEPTOR; OPIATE RECEPTOR; PROGESTERONE; SULFUR 35;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN FUNCTION; CATALYSIS; CELL MEMBRANE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HYPOTHALAMUS; KINETICS; MODULATION; MULTIPLE CYCLE TREATMENT; NONHUMAN; PREOPTIC AREA; PRIORITY JOURNAL; PROTEIN BINDING; RAT; REGULATORY MECHANISM; SEXUAL BEHAVIOR;

ANIMALS; CELL MEMBRANE; ESTROGENS; FEMALE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HYPOTHALAMUS; OPIOID PEPTIDES; PROGESTERONE; PROTEIN BINDING; RATS; RATS, LONG-EVANS; RECEPTORS, OPIOID; SULFUR RADIOISOTOPES; UP-REGULATION;

EID: 47549112900     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000113933     Document Type: Article

References (47)

1. Guide to Receptors and Channels. Br J Pharmacol 2007;147:S61-S62.
2. Sinchak K, Micevych P: Visualizing activation of opioid circuits by internalization of G protein-coupled receptors. Mol Neurobiol 2003;27:197-222.
3. Quesada A, Micevych P: Estrogen and CCK1 receptor modification of mu-opioid receptor binding in the cortex of female rats. Brain Res 2006;1073-1074:316-320.
4. Sinchak K, Micevych PE: Progesterone blockade of estrogen activation of mu-opioid receptors regulates reproductive behavior. J Neurosci 2001;21:5723-5729.
5. Flores CA, Shughrue P, Petersen SL, Mokha SS: Sex-related differences in the distribution of opioid receptor-like 1 receptor mRNA and colocalization with estrogen receptor mRNA in neurons of the spinal trigeminal nucleus caudalis in the rat. Neuroscience 2003;118:769-778.
6. Wagner EJ, Ronnekleiv OK, Grandy DK, Kelly MJ: The peptide orphanin FQ inhibits beta-endorphin neurons and neurosecretory cells in the hypothalamic arcuate nucleus by activating an inwardly-rectifying K+ conductance. Neuroendocrinology 1998;67:73-82.
7. Sinchak K, Romeo HE, Micevych PE: Site-specific estrogen and progestin regulation of orphanin FQ/nociceptin and nociceptin opioid receptor mRNA expression in the female rat limbic hypothalamic system. J Comp Neurol 2006;496:252-268.
8. Mills RH, Sohn RK, Micevych PE: Estrogen-induced mu-opioid receptor internalization in the medial preoptic nucleus is mediated via neuropeptide Y-Y1 receptor activation in the arcuate nucleus of female rats. J Neurosci 2004;24:947-955.
9. Darland T, Heinricher MM, Grandy DK: Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more. Trends Neurosci 1998;21:215-221.
10. Sinchak K, Hendricks DG, Baroudi R, Micevych PE: Orphanin FQ/nociceptin in the ventromedial nucleus facilitates lordosis in female rats. Neuroreport 1997;8:3857-3860.
11. Flores CA, Wang XM, Zhang KM, Mokha SS: Orphanin FQ produces gender-specific modulation of trigeminal nociception: behavioral and electrophysiological observations. Neuroscience 2001;105:489-498.
12. Claiborne J, Nag S, Mokha SS: Activation of opioid receptor like-1 receptor in the spinal cord produces sex-specific antinociception in the rat: estrogen attenuates antinociception in the female, whereas testosterone is required for the expression of antinociception in the male. J Neurosci 2006;26:13048-13053.
13. Meunier JC: Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur J Pharmacol 1997;340:1-15.
14. Manabe T, Noda Y, Mamiya T, Katagiri H, Houtani T, Nishi M, Noda T, Takahashi T, Sugimoto T, Nabeshima T, Takeshima H: Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature 1998;394:577-581.
15. Champion HC, Pierce RL, Kadowitz PJ: Nociceptin, a novel endogenous ligand for the ORL1 receptor, dilates isolated resistance arteries from the rat. Regul Pept 1998;78:69-74.
16. Devine DP, Taylor L, Reinscheid RK, Monsma FJ Jr, Civelli O, Akil H: Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. Neurochem Res 1996;21:1387-1396.
17. Bryant W, Janik J, Baumann M, Callahan P: Orphanin FQ stimulates prolactin and growth hormone release in male and female rats. Brain Res 1998;807:228-233.
18. Olszewski PK, Levine AS: Minireview: characterization of influence of central nociceptin/orphanin FQ on consummatory behavior. Endocrinology 2004;145:2627-2632.
19. Nothacker HP, Reinscheid RK, Mansour A, Henningsen RA, Ardati A, Monsma FJ Jr, Watson SJ, Civelli O: Primary structure and tissue distribution of the orphanin FQ precursor. Proc Natl Acad Sci USA 1996;93:8677-8682.
20. Anton B, Fein J, To T, Li X, Silberstein L, Evans CJ: Immunohistochemical localization of ORL-1 in the central nervous system of the rat. J Comp Neurol 1996;368:229-251.
21. Sinchak K, Hendricks DG, Baroudi R, Micevych PE: Orphanin FQ/nociceptin in the ventromedial nucleus facilitates lordosis in female rats. Neuroreport 1997;8:3857-3860.
22. Sinchak K, Dewing P, Cook M, Micevych P: Release of orphanin FQ/nociceptin in the medial preoptic nucleus and ventromedial nucleus of the hypothalamus facilitates lordosis. Horm Behav 2007;51:406-412.
23. Eckersell CB, Popper P, Micevych PE: Estrogen-induced alteration of mu-opioid receptor immunoreactivity in the medial preoptic nucleus and medial amygdala. J Neurosci 1998;18:3967-3976.
24. Dhawan BN, Cesselin F, Raghubir R, Reisine T, Bradley PB, Portoghese PS, Hamon M: International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev 1996;48:567-592.
25. Childers SR: Opioid receptor-coupled second messenger systems. Life Sci 1991;48:1991-2003.
26. Meunier JC, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, Butour JL, Guillemot JC, Ferrara P, Monsarrat B, et al: Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 1995;377:532-535.
27. Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ Jr, Civelli O: Orphanin FQ: A neuropeptide that activates an opioid-like G protein-coupled receptor. Science 1995;270:792-794.
28. Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dollae P, Tzavara E, Hanoune J, Roques BP, Kieffer BL: Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the muopioid-receptor gene. Nature 1996;383:819-823.
29. Vaughan CW, Christie MJ: Increase by the ORL1 receptor (opioid receptor-like1) ligand, nociceptin, of inwardly rectifying K conductance in dorsal raphe nucleus neurones. Br J Pharmacol 1996;117:1609-1611.
30. Micevych PE, Eckersell CB, Holland KL, Smith A: Induction of CCK mRNA levels in the limbic-hypothalamic circuit: time course and site-specific effects of estrogen. J Neurobiol 1996;30:465-479.
31. Micevych PE, Eckersell CB, Sarafzadeh K: Acute Estrogen Stimulates Cholecystokinin (CCK) mRNA Expression in the Limbic-Hypothalamic Circuit of the Female Rat. Washington, Society for Neuroscience, 1996, p 1416.
32. Micevych PE, Eckersell CB, Brecha N, Holland K: Estrogenic modulation of opiate and cholecystokinin systems in the limbic-hypothalamic circuit. Brain Res Bull 1997;44:335-343.
33. Asarian L, Geary N: Cyclic estradiol treatment normalizes body weight and restores physiological patterns of spontaneous feeding and sexual receptivity. Horm Behav 2002;42:461-471.
34. Childers SR: Opioid receptors: pinning down the opiate targets. Curr Biol 1997;7:R695-R697.
35. Hilf G, Gierschik P, Jakobs KH: Muscarinic acetylcholine receptor-stimulated binding of guanosine 5′-O-3-thiotriphosphate to guanine-nucleotide-binding proteins in cardiac membranes. Eur J Biochem 1989;186:725-731.
36. Traynor JR, Nahorski SR: Modulation by mu-opioid agonists of guanosine-5′-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SHSY5Y cells. Mol Pharmacol 1995;47:848-854.
37. Micevych PE, Rissman EF, Gustafsson JA, Sinchak K: Estrogen receptor-alpha is required for estrogen-induced mu-opioid receptor internalization. J Neurosci Res 2003;71:802-810.
38. Munson PJ, Rodbard D: Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980;107:220-239.
39. 35S]Guanylyl-5′- O-(-thio)-triphosphate binding in guinea pig brain. J Comp Neurol 1997;386:562-572.
40. Sim LJ, Xiao R, Childers SR: Identification of opioid receptor-like (ORL1) peptide-stimulated [35S]GTP gamma S binding in rat brain. Neuroreport 1996;7:729-733.
41. Yamada S, Kusaka T, Urayama A, Kimura R, Watanabe Y: In vitro and ex vivo effects of a selective nociceptin/orphanin FQ (N/OFQ) peptide receptor antagonist, CompB, on specific binding of [3H]N/OFQ and [35S]GTPgammaS in rat brain and spinal cord. Br J Pharmacol 2003;139:1462-1468.
42. Breivogel CS, Childers SR: Cannabinoid agonist signal transduction in rat brain: comparison of cannabinoid agonists in receptor binding, G-protein activation, and adenylyl cyclase inhibition. J Pharmacol Exp Ther 2000;295:328-336.
43. Unterwald EM, Rubenfeld JM, Imai Y, Wang JB, Uhl GR, Kreek MJ: Chronic opioid antagonist administration upregulates mu opioid receptor binding without altering mu opioid receptor mRNA levels. Brain Res Mol Brain Res 1995;33:351-355.
44. Adapa ID, Toll L: Relationship between binding affinity and functional activity of nociceptin/orphanin FQ. Neuropeptides 1997;31:403-408.
45. Younglai EV, Wu Y, Foster WG, Lobb DK, Price TM: Binding of progesterone to cell surfaces of human granulosa-lutein cells. J Steroid Biochem Mol Biol 2006;101:61-67.
46. Sinchak K, Hipschman S, Cook M, Micevych P: Nociceptin/Orphanin FQ Afferents of the Medial Preoptic Nucleus. San Diego, Society for Neuroscience, 2004.
47. Shaqura MA, Zollner C, Mousa SA, Stein C, Schafer M: Characterization of mu opioid receptor binding and G protein coupling in rat hypothalamus, spinal cord, and primary afferent neurons during inflammatory pain. J Pharmacol Exp Ther 2004;308:712-718.